Who backs Solarea Bio?
12 investors| Investor | Type |
|---|---|
| Viking Global Investors | Asset manager |
| Joyance Partners | Venture capital |
| Olive Tree Capital | Venture capital |
| S2G Investments | Venture capital |
| BOLD Capital Partners | Venture capital |
| GG 1978 | Venture capital |
| Rising Tide Fund | Venture capital |
| GISEV Family Office | Family office |
| AgeTech Collaborative from AARP | — |
| Massachusetts Biomedical Initiatives | — |
| + 2 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Solarea Bio investors
12 investors are on record for Solarea Bio, including Viking Global Investors, Joyance Partners, Olive Tree Capital and S2G Investments. By type, the record holds 6 venture capital firms, 1 family office and 1 asset manager. The early-stage round in Nov 2025 drew 5 investors.
Free account
More of Solarea Bio with a free account
- ·The complete investor list: 12 names
- ·Watch Solarea Bio: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 12 firms already write checks for companies like Solarea Bio in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View